DrugPatentWatch Database Preview
Daiichi Sankyo Company Profile
What is the competitive landscape for DAIICHI SANKYO, and what generic alternatives to DAIICHI SANKYO drugs are available?
DAIICHI SANKYO has eleven approved drugs.
There are four US patents protecting DAIICHI SANKYO drugs.
Summary for Daiichi Sankyo
| US Patents: | 4 |
| Tradenames: | 9 |
| Ingredients: | 9 |
| NDAs: | 11 |
| Patent Litigation for Daiichi Sankyo: | See patent lawsuits for Daiichi Sankyo |
| PTAB Cases with Daiichi Sankyo as patent owner: | See PTAB cases with Daiichi Sankyo as patent owner |
Drugs and US Patents for Daiichi Sankyo
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Daiichi Sankyo Inc | SAVAYSA | edoxaban tosylate | TABLET;ORAL | 206316-002 | Jan 8, 2015 | RX | Yes | No | 7,365,205 | ➤ Sign Up | Y | ➤ Sign Up | |||
| Daiichi Sankyo Inc | MORPHABOND ER | morphine sulfate | TABLET, EXTENDED RELEASE;ORAL | 206544-001 | Oct 2, 2015 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | |||||
| Daiichi Sankyo Inc | MORPHABOND ER | morphine sulfate | TABLET, EXTENDED RELEASE;ORAL | 206544-003 | Oct 2, 2015 | RX | Yes | No | 7,955,619 | ➤ Sign Up | Y | ➤ Sign Up | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Daiichi Sankyo
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Daiichi Sankyo | WELCHOL | colesevelam hydrochloride | FOR SUSPENSION;ORAL | 022362-002 | Oct 2, 2009 | 5,693,675*PED | ➤ Sign Up |
| Daiichi Sankyo | BENICAR HCT | hydrochlorothiazide; olmesartan medoxomil | TABLET;ORAL | 021532-003 | Jun 5, 2003 | 5,616,599*PED | ➤ Sign Up |
| Daiichi Sankyo | AZOR | amlodipine besylate; olmesartan medoxomil | TABLET;ORAL | 022100-004 | Sep 26, 2007 | 5,616,599*PED | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Paragraph IV (Patent) Challenges for DAIICHI SANKYO drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Tablets | 625 mg | ➤ Subscribe | 2009-07-01 |
| ➤ Subscribe | Tablets | 5 mg/20 mg and 10 mg/40 mg | ➤ Subscribe | 2008-02-11 |
| ➤ Subscribe | Tablets | 5 mg, 20 mg and 40 mg | ➤ Subscribe | 2006-04-25 |
| ➤ Subscribe | Tablets | 40 mg/12.5 mg and 40 mg/25 mL | ➤ Subscribe | 2007-02-15 |
| ➤ Subscribe | Powder for Oral Suspension | 1.875 g/Packet and 3.75 g/Packet | ➤ Subscribe | 2010-04-09 |
| ➤ Subscribe | Tablets | 10 mg/20 mg and 5 mg/40 mg | ➤ Subscribe | 2008-03-31 |
| ➤ Subscribe | Tablets | 20 mg/12.5 mg | ➤ Subscribe | 2007-05-11 |
| ➤ Subscribe | Capsules | 30 mg | ➤ Subscribe | 2009-02-27 |
International Patents for Daiichi Sankyo Drugs
Supplementary Protection Certificates for Daiichi Sankyo Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 0760 | Netherlands | ➤ Sign Up | PRODUCT NAME: EDOXABAN, EEN ZOUT DAARVAN, EEN SOLVAAT DAARVAAN OF EEN N-OXIDE DAARVAN, IN HET BIJZONDER EDOXABAN TOSYLAAT; REGISTRATION NO/DATE: EU/1/15/993 20150619 |
| C0048 | France | ➤ Sign Up | PRODUCT NAME: AMLODIPINE OU UN DE SES SELS D?ADDITION D?ACIDES PHARMACAUTIQUEMENT ACCEPTABLES/ ATORVASTATINE OU UN DE SES SELS PHARMACEUTIQUEMENT ACCEPTABLES; REGISTRATION NO/DATE IN FRANCE: NL 29929 DU 20050707; REGISTRATION NO/DATE AT EEC: NL 29929 DU 20050707 |
| 12/018 | Ireland | ➤ Sign Up | PRODUCT NAME: ALISKIREN OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AMLODIPINE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND HYDROCHLOROTHIAZIDE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF.; NAT REGISTRATION NO/DATE: EU/1/11/730/001-060 20111122; FIRST REGISTRATION NO/DATE: SWITZERLAND 6167801-6167805 20110705 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
